# Chongqing Daxin Pharmaceutical Co., Ltd. – FDA Inspection, May 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/cda74d6b-05ac-44c9-a971-2273e84327b9
Source feed: FDA_Inspections

> FDA inspection 1056109 of Chongqing Daxin Pharmaceutical Co., Ltd., May 11, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1056109
- Company Name: Chongqing Daxin Pharmaceutical Co., Ltd.
- Inspection Date: 2018-05-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1245029 - 2024-06-28
- FDA Inspection 912081 - 2015-01-29

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/joel-d-hustedt/29440042-08dd-4dce-be48-b55f8e1d7080)

Company: https://www.keypedia.com/companies/chongqing-daxin-pharmaceutical-co-ltd/41f80e0d-c994-41e7-aa3f-32c2aabcea04

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
